Literature DB >> 16938130

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.

J W van Werkum, C A K van der Stelt, T H Seesing, C M Hackeng, J M ten Berg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16938130     DOI： 10.1111/j.1538-7836.2006.02187.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  21 in total

1.  Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y12 assay.

Authors:  In-Suk Kim; Young-Hoon Jeong; Min-Kyung Kang; Jin-Sin Koh; Yongwhi Park; Seok-Jae Hwang; Choong Hwan Kwak; Jin-Yong Hwang; Sunjoo Kim
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

2.  Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system.

Authors:  Hiroki Takiuchi; Kazuo Tanemoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-08-23

Review 3.  Clopidogrel Resistance in Lower Extremity Arterial Endovascular Interventions.

Authors:  Kyle M Markel; Efthymios D Avgerinos
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

4.  A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention.

Authors:  Jiyoung Jang; Jihyang Lim; Kiyuk Chang; Yonggoo Kim; Myungshin Kim; Hae Il Park; Jayoung Kim; Soyoung Shin
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

Review 5.  Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.

Authors:  Nalyaka Sambu; Nick Curzen
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 6.  Platelet function testing and tailored antiplatelet therapy.

Authors:  Paul W A Janssen; Jurriën M ten Berg
Journal:  J Cardiovasc Transl Res       Date:  2013-03-30       Impact factor: 4.132

Review 7.  Monitoring aspirin and clopidogrel response: testing controversies and recommendations.

Authors:  Athanasios Karathanos; Tobias Geisler
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

8.  Point-of-care platelet function testing in patients undergoing PCI: between a rock and a hard place.

Authors:  J W van Werkum; C M Hackeng; F I de Korte; F W A Verheugt; J M Ten Berg
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

9.  The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation.

Authors:  Kyounghoon Lee; Seung-Whan Lee; Jun-Won Lee; Seong-Yoon Kim; Young-Jin Youn; Min-Soo Ahn; Jang-Young Kim; Byung-Su Yoo; Junghan Yoon; Kyung-Hoon Choe
Journal:  Korean Circ J       Date:  2009-12-30       Impact factor: 3.243

Review 10.  Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Nicholas B Norgard; Mazen Abu-Fadel
Journal:  Vasc Health Risk Manag       Date:  2009-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.